The pivotal Phase III clinical trial will commence in Q3 2023, pending the availability of clinical supply from Procaps Group and the allocation of shortfall required to conclude Avecho’s current capital raise.
The pivotal Phase III clinical trial will commence in Q3 2023,...
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $1.801K | 512.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 94441246 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 20308827 | 11 |
View Market Depth
| Last trade - 15.46pm 06/05/2024 (20 minute delay) ? |
| AVE (ASX) Chart |